TME Pharma N.V. (PA:ALTME) — Stock Price

€0.06 EUR
▲ 1.44% today

TME Pharma N.V. (PA:ALTME) is currently trading at €0.06 EUR, up 1.44% today. Over the past 52 weeks, shares have ranged between €0.05 and €0.11. This page tracks TME Pharma N.V.'s live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see TME Pharma N.V. stock valuation.

TME Pharma N.V. (ALTME) Stock Price Chart — Daily History & Trading Volume

The chart below tracks TME Pharma N.V.'s daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

TME Pharma N.V. Income Statement — Revenue, Profit & Earnings by Year

TME Pharma N.V.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €19.00K €17.00K €0.00 €33.00K €35.00
Cost of Revenue €78.00K €144.00K €92.00K €66.00K €63.00K
Gross Profit €-78.00K €-127.00K €-92.00K €-65.97K €-62.97K
Research & Development €2.30 Million €2.65 Million €8.15 Million €10.66 Million €4.02 Million
SG&A €2.98 Million €2.99 Million €1.93 Million €1.26 Million €912.00K
Total Operating Expenses €5.20 Million €5.50 Million €12.00 Million €13.45 Million €5.83 Million
Operating Income €-5.28 Million €-5.62 Million €-12.03 Million €-13.27 Million €-5.77 Million
EBITDA €-5.25 Million €-5.07 Million €-11.63 Million €-12.88 Million €-5.29 Million
EBIT €-5.26 Million €-5.22 Million €-11.73 Million €-12.95 Million €-5.35 Million
Interest Expense €503.00K €1.52 Million €3.40 Million €1.50 Million €5.05 Million
Income Before Tax €-5.72 Million €-6.73 Million €-15.13 Million €-14.45 Million €-10.41 Million
Income Tax Expense €2.00K €7.00K €1.00K €417.00K
Net Income €-5.72 Million €-6.74 Million €-15.13 Million €-14.45 Million €-10.40 Million

TME Pharma N.V. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes TME Pharma N.V.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €2.14 Million €3.41 Million €2.49 Million €5.24 Million €9.77 Million
Total Current Assets €2.12 Million €3.36 Million €2.39 Million €5.01 Million €9.69 Million
Cash & Equivalents €3.24 Million €2.25 Million €4.63 Million €9.46 Million
Short-term Investments €4.00K €5.00K €0.00 €28.00K
Net Receivables €22.00K €26.00K €41.00K €279.00K €81.00K
Inventory €91.00K €74.00K €124.00K
Property, Plant & Equipment €34.00K €96.00K €221.00K €66.00K
Goodwill
Total Liabilities €3.72 Million €1.79 Million €2.79 Million €6.51 Million €5.27 Million
Total Current Liabilities €3.72 Million €1.79 Million €2.79 Million €6.45 Million €5.27 Million
Long-term Debt €0.00
Net Debt €644.00K €-3.24 Million €-1.08 Million €-548.00K €-7.02 Million
Total Stockholder Equity €-1.58 Million €1.61 Million €-294.00K €-1.27 Million €4.51 Million
Retained Earnings €-203.38 Million €-200.09 Million €-194.37 Million €-187.63 Million €-172.50 Million

TME Pharma N.V. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how TME Pharma N.V. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €-3.42 Million €-4.63 Million €-5.63 Million €-12.14 Million €-12.38 Million
Capital Expenditures €0.00 €16.00K €19.00K €21.00K €14.00K
Free Cash Flow €-3.42 Million €-4.65 Million €-5.65 Million €-12.16 Million €-12.39 Million
Investing Cash Flow €8.00K €-21.00K €-19.00K €-21.00K €-14.00K
Financing Cash Flow €2.18 Million €5.66 Million €3.27 Million €7.29 Million €11.50 Million
Dividends Paid
Stock-Based Compensation €312.00K €396.00K €589.00K €475.00K
Depreciation €8.00K €78.00K €144.00K €92.00K €66.00K
Change in Cash €-1.23 Million €995.00K €-2.39 Million €-4.82 Million €-848.00K

TME Pharma N.V. Earnings History — EPS Actual vs. Analyst Estimates

Track TME Pharma N.V.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 30, 2025 -0.02 0.00
Apr 25, 2025 -0.06 0.00
Oct 18, 2024 -0.12 0.00
Apr 24, 2023 -12.86 0.00
Oct 26, 2022 -1146.92 0.00
Apr 22, 2022 -0.11 0.00
Oct 26, 2021 -0.11 0.00
Apr 28, 2021 -0.11 0.00